Piramal Pharma Legal & Regulatory

Piramal Pharma Capital Structure Change

HDFC Mutual Fund schemes reduced their Piramal Pharma stake by 2.027% via open market sale on 28 October 2026. Holding fell from 7.015% to 4.988%.

Piramal Pharma Investor Presentation: Key Takeaways

Q2FY27 revenue ₹2,617 Cr (+28% YoY), EBITDA margin 14.7% (+372 bps), PAT ₹5 Cr vs loss of ₹99 Cr. FY27 revenue growth outlook raised to 19-20%.

Piramal Pharma Results Update

Piramal Pharma released its Q2/H1 FY27 press release reporting revenue of Rs. 2,617 crore for Q2 and Rs. 4,887 crore for H1, with EBITDA up 72%. The filing also upgrades FY27 revenue growth guidance to 19–20%.

Piramal Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹5 Cr

Piramal Pharma Ltd reported revenue from operations of ₹2,617 Cr (+28.1% YoY) and net profit of ₹5 Cr for Q2 FY27.

Key figure

Net profit ₹5 Cr

Piramal Pharma Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026. The report details equity distribution among promoters and public shareholders.

Piramal Pharma Board Meeting Date

Piramal Pharma Limited has scheduled a board meeting on October 27, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.

B L Kashyap & Sons Legal & Regulatory

Board noted NSE's ₹48,000 fine for delayed Q2 shareholding pattern filing under Regulation 31. Company paid the fine and directed stronger compliance controls.

Value

₹0.00 Cr

Sterling and Wilson Renewable Energy Legal & Regulatory

SWSOLAR's ICC arbitration with TSGF SPA extended until March 31, 2027. A conditional settlement was executed with no financial impact until implementation.

Committed Cargo Care Legal & Regulatory

Supreme Court upheld NCLT order directing CCCL's directors to personally pay ₹2 Crore to Stockflow's estate. No liability attaches to the Company itself.

Value

₹2.00 Cr

SRG Housing Finance Legal & Regulatory

SRG Housing Finance will miss the 14 November 2026 deadline for its September 2026 half-year results. The delay is due to a forensic audit initiated by the National Housing Bank.

Cupid Breweries & Distilleries Legal & Regulatory

Cupid Breweries received a SEBI administrative warning letter dated 6 November 2026 for a SAST Regulation 22(2A) violation over preferential allotment shares credited to personal demat accounts. The company states there was no financial or operational impact.

Hindustan Copper Legal & Regulatory

Hindustan Copper sought exemption from BSE and NSE fines of Rs.14.43 lakh each for board-composition non-compliance. Four independent director vacancies await Government appointment.

Value

₹0.29 Cr